Clinical Trial Update: Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial comparing nebulized procaterol to nebulized salbutamol for moderate acute asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Nebulized Procaterol (procaterol)
• Nebulized salbutamol (salbutamol)

Snippet

Sponsor: PT Otsuka Indonesia | Conditions: Moderate Acute Asthma | Phase 3 | Status: COMPLETED